These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15282399)

  • 1. Urinary leukotriene LTE4 levels in non-responders to antileukotriene therapy.
    Lee DK
    Thorax; 2004 Aug; 59(8):727; author reply 727. PubMed ID: 15282399
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary leukotriene E4.
    Rabinovitch N
    Immunol Allergy Clin North Am; 2007 Nov; 27(4):651-64; vii. PubMed ID: 17996582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease.
    Field JJ; Strunk RC; Knight-Perry JE; Blinder MA; Townsend RR; DeBaun MR
    Am J Hematol; 2009 Apr; 84(4):231-3. PubMed ID: 19291727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha.
    Tanaka H; Saito T; Kurokawa K; Teramoto S; Miyazaki N; Kaneko S; Hashimoto M; Abe S
    Allergy; 1999 May; 54(5):489-94. PubMed ID: 10380781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The therapeutic potentials of antileukotriene preparations in bronchial asthma patients].
    Fedoseev GB; Emel'ianov AV; Krasnoshchekova OI
    Ter Arkh; 1998; 70(8):81-4. PubMed ID: 9770758
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation.
    Green SA; Malice MP; Tanaka W; Tozzi CA; Reiss TF
    Thorax; 2004 Feb; 59(2):100-4. PubMed ID: 14760145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [May the Force be with antileukotriene drugs].
    Szczeklik A
    Pneumonol Alergol Pol; 2010; 78(1):1-2. PubMed ID: 20162512
    [No Abstract]   [Full Text] [Related]  

  • 8. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
    Rabinovitch N; Strand M; Stuhlman K; Gelfand EW
    J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary leukotriene E4 as a biomarker of exposure, susceptibility and risk in asthma.
    Rabinovitch N
    Immunol Allergy Clin North Am; 2012 Aug; 32(3):433-45. PubMed ID: 22877620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
    Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
    J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of urinary leukotriene E4 levels in asymptomatic bronchial asthma].
    Yamamoto H; Kuramitsu K; Houya I; Maruo H; Sakata K; Tabe K; Kimura I; Inoue K; Shibasaki M; Yamamoto K; Sakamoto Y; Matsuo H
    Arerugi; 1996 Oct; 45(10):1106-11. PubMed ID: 8958657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of supportive treatment such as antioxidant or leukotriene receptor antagonist drugs on inflammatory and respiratory parameters in asthma patients.
    Tug T; Godekmerdan A; Sari N; Karatas F; Erdem ES
    Clin Pharmacol Ther; 2007 Mar; 81(3):371-6. PubMed ID: 17339866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antileukotrienes in the therapy of bronchial asthma].
    Rossi G
    Recenti Prog Med; 1998 Dec; 89(12):654-6. PubMed ID: 9951316
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of anti-leukotriene drugs in the management of chronic asthma].
    Adachi M; Imai T; Minoguchi K
    Arerugi; 1999 Jul; 48(7):683-5. PubMed ID: 10481351
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antileukotriene drugs in the treatment of obstructive lung diseases and rhinitis].
    Mastalerz L; Kania A
    Pneumonol Alergol Pol; 2010; 78(1):74-8. PubMed ID: 20162522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antileukotriene drugs: a new treatment for asthma].
    Armetti L; Nicosia S
    Boll Chim Farm; 1999 Dec; 138(11):599-605. PubMed ID: 10765473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Leukotriene modifiers: the role in the treatment of childhood asthma].
    Tal A
    Harefuah; 1999 Jun; 136(11):889-92. PubMed ID: 10955139
    [No Abstract]   [Full Text] [Related]  

  • 18. Asthma.
    Dennis R; Solarte I; Fitzgerald JM
    Clin Evid; 2004 Jun; (11):1966-97. PubMed ID: 15652092
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukotriene receptor antagonists as first line or add-on treatment for asthma.
    Ducharme FM
    BMJ; 2011 Sep; 343():d5314. PubMed ID: 21914735
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in therapy with antileukotriene drugs.
    Riccioni G; Di Ilio C; Conti P; Theoharides TC; D'Orazio N
    Ann Clin Lab Sci; 2004; 34(4):379-87. PubMed ID: 15648777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.